Eli Lilly's Obesity Drug Development
This is a news story, published by CNBC, that relates primarily to Dan Skovronsky news.
Dan Skovronsky news
For more Dan Skovronsky news, you can click here:
more Dan Skovronsky newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsCNBC news
For more news from CNBC, you can click here:
more news from CNBCAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
obesity drugs Lilly. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest good obesity drug news, more weight loss news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
newer obesity medicinesCNBC
•Health
Health
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs

64% Informative
Eli Lilly Chief Scientific Officer Dan Skovronsky said obesity medicines need to deliver more than just weight loss.
Skovronky said he is most excited about treating more health conditions with GLP-1s and other incretin medicines.
He sees improving ease of use and making more potent drugs as two paths to move the field forward.
VR Score
59
Informative language
55
Neutral language
73
Article tone
semi-formal
Language
English
Language complexity
46
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links